Showing results (161-170 of 204) with videos related to
Sort By:
Pageof 21
Plos One|August 14, 2013
Phosphorylation of the actin binding protein Drebrin at S647 is regulated by neuronal activity and PTENPatricia Kreis, Rita Hendricusdottir, Louise Kay, et al.The Journal of Clinical Investigation|October 3, 2008
PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viabilityAna Silva, J Andrés Yunes, Bruno A Cardoso, et al.Cancers|June 26, 2025
Steroid Sulfatase Regulates Metabolic Reprogramming in Advanced Prostate CancerMasuda Sharifi, Cameron M Armstrong, Shu Ning, et al.Iscience|February 8, 2024
IGFBP3 promotes resistance to Olaparib via modulating EGFR signaling in advanced prostate cancerAmy R Leslie, Shu Ning, Cameron M Armstrong, et al.Diabetes Care|June 6, 2013
Characterization of renal glucose reabsorption in response to dapagliflozin in healthy subjects and subjects with type 2 diabetesRalph A DeFronzo, Marcus Hompesch, Sreeneeranj Kasichayanula, et al.Nucleic Acids Research|April 24, 2018
Visualizing structure-mediated interactions in supercoiled DNA moleculesShane Scott, Zhi Ming Xu, Fedor Kouzine, et al.Molecular Cancer Therapeutics|January 28, 2022
Olaparib-Induced Senescence Is Bypassed through G2-M Checkpoint Override in Olaparib-Resistant Prostate CancerAlan P Lombard, Cameron M Armstrong, Leandro S D'Abronzo, et al.Disease Models & Mechanisms|April 21, 2017
Generation of a multipurpose Prdm16 mouse allele by targeted gene trappingAlexander Strassman, Frank Schnütgen, Qi Dai, et al.Cancer Research Communications|October 23, 2024
PINK1-Mediated Mitochondrial Activity Confers Olaparib Resistance in Prostate Cancer CellsZachary A Schaaf, Shu Ning, Amy R Leslie, et al.Molecular Cancer Therapeutics|August 5, 2022
Bioengineered BERA-Wnt5a siRNA Targeting Wnt5a/FZD2 Signaling Suppresses Advanced Prostate Cancer Tumor Growth and Enhances Enzalutamide TreatmentShu Ning, Chengfei Liu, Wei Lou, et al.Pageof 21